Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Markets
Results
Mutual Funds
F&O
Reports
Stock screeners
Subscribe
Superstars
Portfolio
Watchlist
Alerts
Insider Trading & SAST
What's New
Trendlyne Baskets
Gainers/Losers
Sector Rotation
Analyst Estimates
Results
Calendar
Tools
News by Trendlyne
Insider Trades
Global Indices
CEO Salary Dashboard
FAQs
S&P
16 Jul, 2026 5:30 PM (EDT)
7555.54
-35.65
(
-0.47
%)
16 Jul, 2026 5:30 PM (EDT)
372
129
DOW
16 Jul, 2026 5:30 PM (EDT)
52569.33
-94.63
(
-0.18
%)
16 Jul, 2026 5:30 PM (EDT)
23
7
US TECH COMPOSITE
16 Jul, 2026 5:30 PM (EDT)
25910.14
-371.21
(
-1.41
%)
16 Jul, 2026 5:30 PM (EDT)
1262
1478
Industry - Industrial Specialties stocks today: Real-time Stock Market Dashboard
Industry - Industrial Specialties: see top gainers, losers, volume screeners, and more
All Portfolio
All Watchlist
What's Happening
View all
16 Jul 2026
Etsy Inc
Analyst Downgrade
BTIG downgrades Etsy to 'Neutral'; cites a balanced risk-reward profile after a strong rally
Ero Copper Corp
Analyst Upgrade
BofA upgrades Ero Copper to 'Buy'; raises the target price to $34 citing attractive valuation
Uber
Takeover Bid
Uber launches $14.8 bn takeover bid for Delivery Hero to expand global presence in food delivery
Taiwan Semiconductor Manufacturing (ADR)
Investment
TSMC announces another $100 billion investment in the US to build "four or more" fabs in Arizona
Unitedhealth Grp
Positive Outlook
UnitedHealth raises FY26 EPS outlook by 9.3% to $19.5–20 on better pricing and cost control
Tenaris S.A. (ADR)
Analyst Upgrade
Morgan Stanley upgrades Tenaris to 'Equalweight'; raises the target price to $65 on rising demand
Jabil
Buyback
Jabil's board of directors approves a share repurchase program worth $1.5 billion
ManpowerGroup
Estimates Beat
ManpowerGroup's Q2 revenue beats estimates by 3.6%, led by demand in the US, Latin America & Europe
Abbott
Rising Revenue
Abbott Labs' Q2 revenue jumps 13% YoY to $12.6 bn, on higher diagnostics and medical devices sales
Imax Corp
Analyst Downgrade
Wells Fargo downgrades Imax to 'Equalweight'; cuts the target to $41 on limited upside potential
State Street
Estimates Beat
State Street's Q2 EPS beats Forecaster estimates by 10%, led by higher management & servicing fees
Eli Lilly
Acquisition
Eli Lilly to acquire AtaiBeckley for up to $3.8 bn, gaining access to DMT- and MDMA-based drugs
GE HealthCare Tech
Partnership
GE HealthCare secures a $500 mn Care Alliance partnership to expand its AI and imaging ecosystem
NVIDIA
Partnership
Nvidia partners with Japan robotics firms Fanuc and Yaskawa Electric to develop robotics and AI
Alphabet (Class C)
Superstar View
Warren Buffet, holding 0.5% stake in Alphabet, sees the stock beating 90-95% of Wall Street's picks
15 Jul 2026
BlackRock
Estimates Beat
BlackRock surges on Wed as Q2 EPS beats Forecaster estimates by 9.6%, led by net inflow of $192 bn
CNX Resources Corp
Analyst Upgrade
Truist upgrades CNX Resources to 'Hold' over its strategic asset acquisitions
Arm Holdings PLC. (ADR)
Analyst Downgrade
HSBC downgrades Arm Holdings to a 'Hold' rating; cites valuation concerns
Newmont
Analyst Upgrade
TD Cowen upgrades Newmont Corp to 'Buy'; cites an attractive valuation
Elevance Health
Falling Membership
Elevance Health's Q2 membership drops 1% QoQ to 44.9 mn due to rate hikes on Affordable Care Act
Pentair
Negative Outlook
Pentair lowers 2026 sales guidance by 8.1% to $3.95 bn, citing falling sales in the pool segment
Allstate
Analyst Downgrade
UBS downgrades Allstate Corp to 'Neutral'; cites concerns over its future profit margins
Conagra Brands
Negative Outlook
Conagra projects FY27 revenue to decline 1-3% due to weak consumer demand and input cost pressures
Celcuity Inc
FDA Approval
Celcuity gets US FDA approval for a breast cancer drug with over $10 billion market opportunity
Morgan Stanley
Estimates Beat
Morgan Stanley’s Q2 revenue beats estimates by 8.7%, driven by a 69% surge in equities trading
View More
Sector Heatmap
View all
Top Gainers Stocks
View all
Top Losers Stocks
View all
New 52 Week High
View all
New 52 Week Low
View all
Relative Outperformance versus S&P 500 over 1 Week
View all
Relative Underperformance versus S&P 500 over 1 Week
View all
Volume Shockers
View all
High Volume, High Gain
View all
High Volume, Top Losers
View all
Positive Breakout Third Resistance (LTP > R3)
View all
Sectors Performance
Most Popular Stock Screeners